financial trading

Amazon’s real growth strategy will continue to drive upside in AMZN stock for years to come.

Amazon’s(NSDQ:AMZN)growth inside and outside the United States has been relentless in the last ten years, and their double-digit growth has continued even after the company crossed over into the 100-billion-dollar annual sales territory. As the top line gets bigger and bigger, sustaining near 20% growth rate is difficult, but Amazon has managed to keep that growth rate mostly intact despite increasing competition in the e-commerce space.

The problem for Amazon is that the company is not creating a new market: it is actually taking market share from existing players. Its a well-known secret that Amazons basket of retail products is not the cheapest, but customers still keep flocking to the e-tailer in droves as it offers unparalleled convenience. (See also:Is Amazon.com, Inc. (AMZN) Becoming A Threat To Alphabet Inc (GOOGL)?

financial trading: Vicon Industries Inc.(VII)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows Digital Ally back to below the level it was at five years ago whiledirect competitorAxon Enterprise has outperformed along withsecurity stock Napco Security Technologies Inc (NASDAQ: NSSC), but video management software stockVicon Industries, Inc (NYSEMKT: VII) has underperformed:

financial trading: Kindred Healthcare, Inc.(KND)

Advisors’ Opinion:

  • [By Lisa Levin]

    Kindred Healthcare, Inc. (NYSE: KND) shares shot up 31 percent to $7.85. Kindred Healthcare reported Q3 adjusted loss of $0.33 per share on revenue of $1.477 billion.

  • [By Lisa Levin]

    Tuesday afternoon, healthcare shares gained by 0.61 percent. Meanwhile, top gainers in the sector included Kindred Healthcare, Inc. (NYSE: KND), and QLT Inc. (USA) (NASDAQ: QLTI).

financial trading: FORM Holdings (FH)

Advisors’ Opinion:

  • [By Matthew Briar]

    Looking for a quick, money-making trading idea? Put FORM Holdings Corp. (NASDAQ:FH) on your watchlist, if not yet in your portfolio. FH shares are knocking on the door of a breakout move, and one more nudge could do the trick.

    There are a couple of factors in play here. One of the is the converging wedge pattern that’s developed after the October-December finally stabilized. The upper boundary of that wedge at $2.40 has been tested several times since late last year, but FORM Holdings could never get past the hurdle. At the same time, several key moving average lines seem to be acting as support — even if unevenly — keeping FH positioned well for a breakout effort.

financial trading: Kelly Services Inc.(KELYA)

Advisors’ Opinion:

  • [By David Milstead]

    One such outfit is Kelly Services (KELYA). The Troy, Mich., company places temporary employees in a variety of fields, such as law, health care, computing and finance. Although recent job reports have been strong, S&P Capital IQ analyst Michael Jaffe sees employers remaining cautious in their hiring practices and using the kind of temporary workers Kelly specializes in. Jaffe says Kelly is his top pick in the staffing sector, and he rates the stock a strong buy.

  • [By Monica Gerson]

    Kelly Services, Inc. (NASDAQ: KELYA) is projected to report its quarterly earnings at $0.28 per share on revenue of $1.35 billion.

    Silver Standard Resources Inc. (USA) (NASDAQ: SSRI) is expected to post a quarterly loss at $0.02 per share on revenue of $96.25 million.

financial trading: Tile Shop Hldgs, Inc.(TTS)

Advisors’ Opinion:

  • [By Lisa Levin]

    Tile Shop Hldgs, Inc. (NASDAQ: TTS) shares dropped 23 percent to $15.68 after the company reported downbeat Q2 results.

    Shares of Telefonaktiebolaget LM Ericsson (NASDAQ: ERIC) were down 16 percent to $6.09 after the company posted disappointing quarterly earnings. Ericsson posted Q2 operating loss of 1.2 billion Swedish crowns ($145.3 million), versus a year-ago profit of 2.8 billion Swedish crowns.

financial trading: Opexa Therapeutics, Inc.(OPXA)

Advisors’ Opinion:

  • [By Lisa Levin]

    Opexa Therapeutics Inc (NASDAQ: OPXA) shares were also up, gaining 66 percent to $1.08 after the company announced plans to acquire Acer Therapeutics.

  • [By Elizabeth Balboa]

    Opexa Therapeutics Inc (NASDAQ: OPXA) and Acer Therapeutics announced a merger that will result in 11.2-percent ownership by current Opexa shareholders and 88.8-percent ownership by current Acer shareholders.

  • [By Lisa Levin]

    Opexa Therapeutics Inc (NASDAQ: OPXA) shares dropped 70 percent to $1.02 after the company disclosed that its top-line results from Phase 2b Abili-T trial evaluating Tcelna did not meet primary endpoint.

Leave a Reply

Your email address will not be published. Required fields are marked *